Correspondence to "Oral immunotherapy in alpha-gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?"
- PMID: 38340015
- DOI: 10.1111/all.16048
Correspondence to "Oral immunotherapy in alpha-gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?"
Comment on
-
Oral immunotherapy in alpha-gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?Allergy. 2023 Dec;78(12):3241-3251. doi: 10.1111/all.15840. Epub 2023 Aug 7. Allergy. 2023. PMID: 37545316
References
REFERENCES
-
- Ünal D, Eyice‐Karabacak D, Kutlu A, et al. Oral immunotherapy in alpha‐gal red meat allergy: could specific IgE be a potential biomarker in monitoring management? Allergy. 2023;78(12):3241‐3251. doi:10.1111/all.15840
-
- Gonzalez‐Quintela A, Dam Laursen AS, Vidal C, Skaaby T, Gude F, Linneberg A. IgE antibodies to alpha‐gal in the general adult population: relationship with tick bites, atopy, and cat ownership. Clin Exp Allergy. 2014;44(8):1061‐1068. doi:10.1111/cea.12326
-
- Rutkowski K, Wagner A, Rutkowski R, Sowa P, Pancewicz S, Moniuszko‐Malinowska A. Alpha‐gal syndrome: an emerging cause of food and drug allergy. Clin Exp Allergy. 2020;50(8):894‐903. doi:10.1111/cea.13683
-
- Swiontek K, Morisset M, Codreanu‐Morel F, et al. Drugs of porcine origin‐a risk for patients with α‐gal syndrome? J Allergy Clin Immunol Pract. 2019;7(5):1687‐1690.e3. doi:10.1016/j.jaip.2018.12.005
-
- Lin C, Lee IT, Sampath V, et al. Combining anti‐IgE with oral immunotherapy. Pediatr Allergy Immunol. 2017;28(7):619‐627. doi:10.1111/j.pop.2022.11.006
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical